SCHEDULE 13G: Champlain Investment Partners Discloses 4.4% Stake in AtriCure, Inc.
Ownership Disclosure
Champlain Investment Partners, LLC has filed a Schedule 13G, revealing a 4.4% beneficial ownership stake in medical device company AtriCure, Inc.
Summary
- Champlain Investment Partners, LLC, an investment adviser based in Vermont, has filed a Schedule 13G with the SEC.
- The filing indicates that Champlain Investment Partners beneficially owns 2,137,963 shares of AtriCure, Inc.'s Common Stock.
- This ownership represents 4.4% of the total class of AtriCure, Inc. securities.
- Champlain Investment Partners holds sole voting power over 1,411,908 shares and sole dispositive power over all 2,137,963 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of AtriCure, Inc.
Sentiment
Score: 5
Explanation: The document is a factual ownership disclosure (Schedule 13G) and does not contain information that would inherently lead to a positive or negative sentiment. It simply reports a beneficial ownership stake below the 5% threshold for a 13D filing, indicating no intent to influence control.
Positives
- Champlain Investment Partners, a recognized investment adviser, has taken a significant, albeit non-controlling, stake in AtriCure, Inc., potentially signaling confidence in the company's long-term prospects.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing is a standard disclosure of institutional ownership in a publicly traded company within the medical device sector. It reflects an investment firm's position rather than a strategic industry move or operational update from AtriCure, Inc. itself.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, confirming a non-activist position.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement |
| 05/14/2025 | Date of signature by Champlain Investment Partners, LLC |
Keywords
AtriCure Inc., Champlain Investment Partners, Schedule 13G, Ownership Disclosure, Common Stock, Investment Adviser, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.